Oncology Institute Inc. CW-22STLNWPreferred / convertible
13F holders, Q1 2025 (March 31)11holders −3
0new positions
3sold out
$0.03avg. 13F price*
At the end of Q1 2025, 11 institutions reported holding Oncology Institute Inc. CW-22 (STLNW) in their 13F filings, down 3 from Q4 2024. 0 opened new positions and 3 sold out. The largest holders were LMR Partners LLP ($44K), Deerfield Management Company, L.P. ($34K) and Davidson Kempner Capital Management LP ($9K).
- Company
- Oncology Institute Inc. CW-22
- Filed as
- THE ONCOLOGY INSTITUTE INC (Q1 2025)
- CUSIP
- 68236X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $368 |
All 13F filers, Q4 2024 → Q1 2025: 5,000 shares bought and 68,974 shares sold, net −63,974 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| LMR Partners LLP | — | No change | 1,624,856 | $44K |
| Deerfield Management Company, L.P. | — | No change | 1,250,000 | $34K |
| Davidson Kempner Capital Management LP | — | No change | 318,710 | $9K |
| Man Group plc | — | No change | 88,824 | $2K |
| Healthcare of Ontario Pension Plan Trust Fund | — | No change | 87,500 | $2K |
| Wolverine Asset Management LLC | — | Reduce -3.2% | 72,316 | $2K |
| Alpine Global Management, LLC | — | No change | 25,024 | $678 |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 25,000 | $677 |
| FreeGulliver LLC | — | No change | 18,500 | $501 |
| Clear Street LLC | — | Add +307.1% | 6,628 | $180 |
| UBS Group AG | — | Reduce -2.7% | 3,021 | $82 |
"% of holder's portfolio" is STLNW's weight in each manager's 13F, not the share of Oncology Institute Inc. CW-22 the manager owns.